help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 43, No. 1 236-239
doi:10.1210/jcem-43-1-236
Copyright © 1976 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brown, G. M.
Right arrow Articles by Stancer, H. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brown, G. M.
Right arrow Articles by Stancer, H. C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*HYDROCORTISONE

EFFECT OF CARBIDOPA ON PROLACTIN, GROWTH HORMONE AND CORTISOL SECRETION IN MAN

Gregory M. Brown, Paul E. Garfinkel, Jerry J. Warsh and Harvey C. Stancer

Clarke Institute of Psychiatry Toronto, Ontario, Canada M5T 1R8

Serum prolactin, growth hormone and cortisol levels were examined in normal volunteers following administration of carbidopa, a peripheral decarboxylase inhibitor. 24-hour urinary tryptamine levels dropped markedly indicating that inhibition of decarboxylase was effective. Prolactin levels rose while growth hormone and cortisol remained unchanged. Since the tuberoinfundibular dopamine nerve terminals lie outside the blood brain barrier, this study suggests that these neurons are involved in prolactin but not in growth hormone or cortisol regulation. Findings are compatible with two alternate hypotheses — either that dopamine is a physiologic prolactin inhibiting factor (PIF) or that tuberoinfundibular dopamine neurons regulate the release of PIF.

Received March 2, 1976.




This article has been cited by other articles:


Home page
Arch Gen PsychiatryHome page
B. Birmaher, J. Kaufman, D. A. Brent, R. E. Dahl, l. M. Perel, M. Al-Shabbout, B. Nelson, S. Stull, U. Rao, G. S. Waterman, et al.
Neuroendocrine Response to 5-Hydroxy-L-Tryptophan in Prepubertal Children at High Risk of Major Depressive Disorder
Arch Gen Psychiatry, December 1, 1997; 54(12): 1113 - 1119.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
N. D. Ryan, B. Birmaher, J. M. Perel, R. E. Dahl, V. Meyer, M. Al-Shabbout, S. Iyengar, and J. Puig-Antich
Neuroendocrine Response to L-5-Hydroxytryptophan Challenge in Prepubertal Major Depression: Depressed vs Normal Children
Arch Gen Psychiatry, November 1, 1992; 49(11): 843 - 851.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
C. A. Tamminga, R. C. Smith, G. Pandey, L. A. Frohman, and J. M. Davis
A Neuroendocrine Study of Supersensitivity in Tardive Dyskinesia
Arch Gen Psychiatry, October 1, 1977; 34(10): 1199 - 1203.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1976 by The Endocrine Society